LGC’s ValuPanel Reagents help public laboratories detect SARS-CoV-2 and influenza
Each line of ValuPanel Reagents consists of separately delivered probes and primers, which allow assay flexibility and sizes that can help facilitate scale-up
Each line of ValuPanel Reagents consists of separately delivered probes and primers, which allow assay flexibility and sizes that can help facilitate scale-up
AI could hold the key to more targeted treatment, according to new research
Reserve your place today for talks on topics ranging from food fraud, spatial infiltration and CRISPR to antibody and AAV gene therapies
CE marked assay based on well-established ELISA technology expands Euroimmun's offerings for labs that seek to understand immune response to COVID-19
Explore topics from in vitro diagnostics, flow cytometry, pharmaceutical solid-phase microextraction, liquid handling and much more
An MIT team has created polymers that replicate the structure of mucins, the molecules that give mucus its unique antimicrobial properties
The program was developed in partnership with Color Health, Inc., a California-based leader in distributed healthcare services
Amanda Kulwicki, Global Brand Manager at Thermo Fisher Scientific, discusses how her team ensures sample integrity with confidence
Lateral flow assays are empowering the fight against COVID-19 and in this article, experts in the field tell us more about this technology, highlighting recent advances and challenges
This collaboration enables improved integration of software and robotics platforms to maximize COVID-19 testing throughput and efficiency
Catch up on this on-demand webinar and register for part 2 to learn everything you need to know to get ready for IVDR
Explore topics from immuno-oncology, Raman spectroscopy, in vitro diagnostics, and clinical research
Potent antibodies shown to retain binding to major COVID-19-causing “South African” variant
The partnership will accelerate clinical validation and commercialization of certain NGS, mass spectrometry and immunology diagnostic tools
Twist Biopharma will leverage its biologics and proprietary discovery capabilities to find novel GPCR target-specific antibodies for Kyowa Kirin
Innovative qPCR platform simplifies molecular diagnostic workflows for infectious disease, oncology and COVID-19 testing
The assay has the ability to sequence and surveil evolution of virus mutations over time and geography
This partnership aims to offer an accelerated route to market rapid test technologies